BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35134316)

  • 1. Bioinformatics analysis deciphering the transcriptomic signatures associated with signalling pathways and prognosis in the myelodysplastic syndromes.
    Tuerxun N; Wang J; Zhao F; Qin YT; Wang H; Chen R; Hao JP
    Hematology; 2022 Dec; 27(1):214-231. PubMed ID: 35134316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioinformatics Analysis of Core Genes and Key Pathways in Myelodysplastic Syndrome].
    Wang Y; Wang YS; Hu NB; Teng GS; Zhou Y; Bai J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):804-812. PubMed ID: 35680809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of latent core genes and pathways associated with myelodysplastic syndromes based on integrated bioinformatics analysis.
    Zhu Y; Wu L
    Hematology; 2020 Dec; 25(1):299-308. PubMed ID: 32772642
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression and clinical significance of RAG1 in myelodysplastic syndromes.
    Huang X; Liang X; Zhu S; Xie Q; Yao Y; Shi Z; Liu Z
    Hematology; 2022 Dec; 27(1):1122-1129. PubMed ID: 36166051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of ferroptosis-related genes in patients with Myelodysplastic neoplasms.
    Chen X; Li C; Wang Y; Geng S; Xiao M; Zeng L; Deng C; Li M; Huang X; Weng J; Du X; Lai P
    Hematology; 2023 Dec; 28(1):2288475. PubMed ID: 38038045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and identification of key candidate genes and pathways in myelodysplastic syndrome by bioinformatic analysis.
    Le Y
    PeerJ; 2019; 7():e8162. PubMed ID: 31803541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.
    Li DF; Tulahong A; Uddin MN; Zhao H; Zhang H
    Math Biosci Eng; 2021 Jul; 18(5):6527-6551. PubMed ID: 34517544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Vital Hub Genes and Potential Molecular Pathways of Dermatomyositis by Bioinformatics Analysis.
    Ouyang X; Zeng Y; Jiang X; Xu H; Ning Y
    Biomed Res Int; 2021; 2021():9991726. PubMed ID: 34580642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.
    Xu L; Tong T; Wang Z; Qiang Y; Ma F; Ma X
    Am J Med Sci; 2020 Apr; 359(4):226-234. PubMed ID: 32200915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Myelodysplastic Syndromes.
    Wen J; Luo Q; Wu Y; Zhu S; Miao Z
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key microRNAs and genes associated with abdominal aortic aneurysm based on the gene expression profile.
    Yang P; Cai Z; Wu K; Hu Y; Liu L; Liao M
    Exp Physiol; 2020 Jan; 105(1):160-173. PubMed ID: 31553078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrative bioinformatics analysis of microarray data for identifying hub genes as diagnostic biomarkers of preeclampsia.
    Liu K; Fu Q; Liu Y; Wang C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31416885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.